Standing Ovation

Standing Ovation essentially replicates caseins in a lab setting, and it achieves this through a “precision fermentation” process to recreate what is a core ingredient for non-animal, lactose-free dairy substitutes.

Standing Ovation has raised €49M across 4 funding rounds from 15 investors, most recently a Series B round in Mar 2026. Based in Paris, France; active in Foodtech. Data as of 28 Oct 2026.